The Indirect Cost Cap Is Dead — For Now: How Congress Restored Negotiated Rates at DOE, NSF, Commerce and NASA, and Why the Next Fight Is Already Here

For fifteen years, the number almost nobody outside a university sponsored-programs office thought about was the indirect cost rate — the negotiated percentage that reimburses the electricity, the compliance staff, the animal facilities, the data-center depreciation, and the hundred other real costs of doing federally funded research that no single grant line item captures. In 2025 that number became the most contested figure in American science policy. In 2026 it quietly went back to normal — but "normal" is now a truce, not a settlement.

The pivot point was DOE Policy Flash PF-2026-30, issued January 27, 2026. In a single administrative stroke it rescinded every indirect cost cap the Department of Energy had imposed the previous spring: the 15% ceiling on institutions of higher education, the 15% cap on nonprofits, the 15% cap on for-profits, and the 10% cap on state and local governments. It did not do this out of a change of heart. It did it because Congress ordered it to — and the order reached well beyond DOE.

If you run a lab, a research institute, a nonprofit that takes federal money, or a company living on grants and cooperative agreements, this is one of the most consequential funding developments of the year. It affects real dollars you may be leaving on the table right now.

How we got here: the 15% cap and the courts

The story starts in early 2025. In February, NIH announced it would cap indirect cost reimbursement at 15% across all its research grants — a dramatic cut from the negotiated rates of 50%, 60%, even 70% that major research universities carry. The rationale offered was that private foundations often reimburse overhead at 15% or less, so the federal government should too. The counterargument, made loudly by universities and hospitals, was that foundation grants ride on top of infrastructure that federal grants are supposed to help sustain, and that a flat 15% would blow multi-hundred-million-dollar holes in research budgets overnight.

The cap didn't stay confined to NIH. Between April and May 2025, DOE issued its own family of policy flashes — PF-2025-22 (15% for universities), PF-2025-25 (10% for state and local governments), PF-2025-26 (15% for nonprofits), and PF-2025-27 (15% for for-profits). NSF and the Department of Defense floated parallel moves. For a few months in 2025 it looked like the negotiated indirect cost rate agreement — the NICRA, the bedrock of federal research finance — was going to be replaced wholesale by a flat number set in Washington.

Then the courts intervened. A U.S. District Court vacated the DOE university cap on June 30, 2025, following similar injunctions against the NIH policy. The legal theory was consistent: the caps conflicted with existing regulation (2 CFR 200.414, which requires agencies to honor negotiated rates) and were imposed without the process the law demands. Judges blocked implementation repeatedly. But litigation is slow, agency-by-agency, and reversible on appeal — it was never going to be a durable fix.

The durable fix came from Congress.

What H.R. 6938 actually did

The Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 — H.R. 6938 — did something appropriations bills rarely do so bluntly: it wrote indirect cost policy directly into law.

Division B, Title III, Section 313 orders that DOE "shall continue to apply the indirect cost rates, including negotiated indirect cost rates, as described in section 200.414 of title 2, Code of Federal Regulations" — and, critically, prohibits DOE from spending any appropriated funds "to create new, existing, or apply changes to the negotiated indirect cost rates." In plain terms: apply rates exactly as you did in FY 2024, and don't spend a dime trying to change them.

Division A, Title V, Section 542 extends the same restriction to the Department of Commerce, NASA, and the National Science Foundation. So the four agencies that fund a huge share of the physical sciences, space science, oceanic and atmospheric research, and standards work are now all statutorily frozen at their FY 2024 indirect cost posture.

PF-2026-30 is simply DOE complying. It rescinded PF-2025-22, -25, -26, -27, and the associated financial assistance letter (FAL 2025-05), and restored the FY 2024 framework under 2 CFR 200.414. Under that framework, agencies must accept a recipient's negotiated indirect cost rate agreement unless a statute requires a deviation or OMB approves an exception. Recipients without a NICRA can still elect the de minimis rate, which the 2024 Uniform Guidance revision raised to 15% of modified total direct costs.

The window where caps were in force — roughly April 2025 through January 27, 2026 — is now a defined, closed anomaly. And that matters, because awards issued during that window may still carry cap language that costs you money.

The money you may be able to claw back

This is the actionable core, and it's the part most organizations are moving too slowly on. If you hold DOE awards issued between April 2025 and February 2026, there is a concrete five-step recovery playbook:

1. Audit every award issued in that window for language referencing a 15% or 10% indirect cap or a "capped rate." These clauses were inserted programmatically and are easy to miss in a long terms-and-conditions block.
2. Request an administrative modification to strike the cap and restore NICRA-based treatment. PF-2026-30 gives you the standing to ask; the burden is on you to initiate it.
3. Re-budget against your current NICRA to capture the full indirect recovery the cap suppressed. On a large multi-year award, the delta between 15% and a 55% negotiated rate is not a rounding error — it can be six or seven figures.
4. Request supplemental funding where the cap actually reduced your reimbursement below what the negotiated rate would have delivered.
5. Submit adjustment invoices for previously unreimbursed indirect costs where DOE's processes permit.

The same logic applies at Commerce, NASA, and NSF: any award terms drafted during the cap era should be reviewed against the restored FY 2024 standard. Agencies are not going to volunteer these corrections. The recipients who recover the most will be the ones whose research administration offices treat this as a systematic sweep, not a case-by-case afterthought.

Why this is a truce, not peace

Here's the part that should keep sponsored-programs directors from declaring victory: the executive branch has already opened a second front.

In 2026 OMB released a sweeping proposed rule rewriting large parts of federal grantmaking, and it reaches indirect costs from a different angle. Rather than a flat cap — which Congress and the courts have now blocked twice — the proposed rule would:

• Direct agencies to give funding preference to institutions with lower indirect cost rates, with those preferences decided in part by political appointees;
• Disallow entire categories of cost currently billable as indirect — journal subscriptions, organizational memberships, and publication and printing costs, unless pre-approved; and
• Prohibit costs tied to collaborations with certain foreign countries or entities.

Tellingly, OMB stated it "does not intend to consider or respond to" comments on the indirect cost rate negotiation system itself — a signal that the negotiated-rate structure survives, but the government intends to squeeze what counts as an allowable indirect cost and to reward institutions that ask for less. The public comment period closed July 13, 2026. Congress, in the same FY 2026 laws that froze the caps, also flagged concerns about alternative frameworks like the so-called FAIR model, warning it could funnel higher overhead payments to the largest organizations while adding complexity.

So the state of play in August 2026 is this: the blunt instrument — the flat cap — is legally dead at DOE, NSF, Commerce and NASA through the end of the fiscal year. But the fight has moved from the rate to the base: what you're allowed to count, which collaborations are permissible, and whether asking for full recovery quietly costs you competitive standing. For related coverage of the OMB rewrite of the Uniform Guidance and its October 1, 2026 compliance countdown, see our deep dive on the OMB Uniform Guidance binding countdown.

What to do now

Three moves, in priority order:

First, run the recovery sweep. If you held DOE, NSF, Commerce, or NASA awards during the cap window, the clawback playbook above is time-sensitive — appropriations restrictions are annual, and the cleanest window to correct FY 2025-era awards is while the statutory language is fresh and the agencies are actively processing modifications.

Second, pressure-test your indirect cost base. The next round of restrictions targets what counts, not the rate. Inventory the indirect line items most exposed under the OMB proposal — memberships, subscriptions, publication costs — and start documenting direct-cost justifications or pre-approvals where you can. Don't wait for a final rule to discover which of your recoveries just became disallowed.

Third, treat your NICRA as a strategic asset, not a back-office formality. In a funding environment where a lower indirect rate may soon carry competitive weight, the organizations that understand precisely what their negotiated rate covers — and can defend every component of it — are the ones that will hold their recovery while others quietly give it away.

The indirect cost cap was the loudest science-funding fight of 2025. Its quiet reversal in 2026 is a reminder that in federal grants, the durable wins come from statute, not press releases — and that the next contest is usually already underway before the last one is settled.